SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Apple Restores Telegram to App Store After Content Policy Violation 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Jetstar to Charge for Overhead Cabin Bags From February 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Dublin, March 16, 2018 -- The "Global Smoking Cessation Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering.
The Global Smoking Cessation Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
Key Topics Covered:
Executive Summary
Chapter 1 - Therapy Partnering trends in numbers
Partnering in numbers - by year
Partnering in numbers - most active
Partnering in numbers - by industry sector
Partnering in numbers - by deal type
Partnering in numbers - by technology type
Partnering in numbers - by stage of development
Chapter 2 - Most active dealmakers
Chapter 3 - Partnering deals directory
Partnering deals directory - by company A-Z
Partnering deals directory - by deal value
Partnering deals directory - by industry sector
Partnering deals directory - by deal type
Partnering deals directory - by stage of development
Partnering deals directory - by technology area
Chapter 4 - Partnering deals with a contract document
Chapter 5 - M&A in numbers
M&A in numbers - by year
Chapter 6 - M&A deals directory
M&A deals directory - by company A-Z
M&A deals directory - by deal value
Chapter 7 - Financing in numbers
Financing in numbers - by year
Financing in numbers - by financing type
Chapter 8 - Financing deals directory
Financing deals directory - by company A-Z
Financing deals directory - by deal value
Financing deals directory - by financing type
For more information about this report visit https://www.researchandmarkets.com/research/c742cq/global_smoking?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs
